HDL and ASCVD

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Immunology

Background:

• Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of mortality worldwide.
• High-density lipoprotein (HDL) is a critical lipoprotein involved in reverse cholesterol transport.
• Dysfunctional HDL is implicated in the pathogenesis of ASCVD.

Purpose of the Study:

• To elucidate the multifaceted relationship between circulating HDL and ASCVD.
• To explore the cellular actions of HDL in key cell types relevant to atherogenesis.
• To review recent advancements in HDL-targeting therapies for ASCVD.

Main Methods:

• Literature review and synthesis of existing research on HDL and ASCVD.
• Analysis of studies investigating HDL's cellular interactions (endothelial cells, macrophages, T lymphocytes).
• Overview of novel therapeutic strategies modulating HDL function or levels.

Main Results:

• HDL exhibits protective effects against ASCVD through various mechanisms.
• HDL interacts with diverse cell types, influencing inflammatory and metabolic processes within the arterial wall.
• Emerging therapies aim to enhance HDL's atheroprotective functions.

Conclusions:

• The intricate relationship between HDL and ASCVD underscores HDL's therapeutic potential.
• Targeting HDL offers a promising avenue for novel ASCVD treatments.
• Further research into HDL's cellular roles will refine therapeutic strategies.